Industry news

FDA approves world’s first RSV vaccine for use in over 60s

By Catrin Jackson2023-05-10T11:42:00

RSV - United_States_Centers_for_Disease_Control_and_Prevention_logo

Arexvy has been approved for individuals aged 60 years and older

 This is member-only content

To read this article, SIGN IN NOW if you are a TOPRA member.

Not a TOPRA member yet? 

Join now to get access to:

  • Features and specialist articles
  • CPD supplements
  • Comprehensive archive

Become a member today!

Not sure yet?  Read one of our free editorials to see what you’re missing out on!